285 related articles for article (PubMed ID: 36975459)
1. Anal Cancer: The Past, Present and Future.
Gondal TA; Chaudhary N; Bajwa H; Rauf A; Le D; Ahmed S
Curr Oncol; 2023 Mar; 30(3):3232-3250. PubMed ID: 36975459
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the management of anal cancer.
Symer MM; Yeo HL
F1000Res; 2018; 7():. PubMed ID: 30345012
[TBL] [Abstract][Full Text] [Related]
3. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Klas JV; Rothenberger DA; Wong WD; Madoff RD
Cancer; 1999 Apr; 85(8):1686-93. PubMed ID: 10223561
[TBL] [Abstract][Full Text] [Related]
4. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
[TBL] [Abstract][Full Text] [Related]
5. Squamous-cell carcinoma of the anal canal: room for improvement with targeted therapy.
Oliveira S; Teixeira L; Hoff PM; de Gramont A; Tournigand C
Clin Res Hepatol Gastroenterol; 2012 Jun; 36(3):209-13. PubMed ID: 22138064
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy in Anal Cancer.
Dhawan N; Afzal MZ; Amin M
Curr Oncol; 2023 Apr; 30(5):4538-4550. PubMed ID: 37232801
[TBL] [Abstract][Full Text] [Related]
7. Investigational drugs for treating anal cancer and future perspectives.
Bustamante L; Frakes J; Hoffe S; Kim R
Expert Opin Investig Drugs; 2016; 25(1):51-62. PubMed ID: 26560877
[TBL] [Abstract][Full Text] [Related]
8. A 2020 update of anal cancer: the increasing problem in women and expanding treatment landscape.
Lum C; Prenen H; Body A; Lam M; Segelov E
Expert Rev Gastroenterol Hepatol; 2020 Aug; 14(8):665-680. PubMed ID: 32458709
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic Features Associated With Human Papillomavirus/p16 in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
Morris VK; Rashid A; Rodriguez-Bigas M; Das P; Chang G; Ohinata A; Rogers J; Crane C; Wolff RA; Eng C
Oncologist; 2015 Nov; 20(11):1247-52. PubMed ID: 26382740
[TBL] [Abstract][Full Text] [Related]
11. Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
Oliveira SC; Moniz CM; Riechelmann R; Alex AK; Braghirolli MI; Bariani G; Nahas C; Hoff PM
J Gastrointest Cancer; 2016 Mar; 47(1):75-81. PubMed ID: 26691173
[TBL] [Abstract][Full Text] [Related]
12. Survival following salvage abdominoperineal resection for persistent and recurrent squamous cell carcinoma of the anus: do these disease categories affect survival?
Severino NP; Chadi SA; Rosen L; Coiro S; Choman E; Berho M; Wexner SD
Colorectal Dis; 2016 Oct; 18(10):959-966. PubMed ID: 26850085
[TBL] [Abstract][Full Text] [Related]
13. Anal cancer treatment: current status and future perspectives.
Ghosn M; Kourie HR; Abdayem P; Antoun J; Nasr D
World J Gastroenterol; 2015 Feb; 21(8):2294-302. PubMed ID: 25741135
[TBL] [Abstract][Full Text] [Related]
14. A Population-Based Cohort Analysis of Chemoradiation Versus Radiation Alone for Definitive Treatment of Stage I Anal Cancer in Older Patients.
Buckstein M; Arens Y; Wisnivesky J; Gaisa M; Goldstone S; Sigel K
Dis Colon Rectum; 2018 Jul; 61(7):787-794. PubMed ID: 29771796
[TBL] [Abstract][Full Text] [Related]
15. Squamous Cancers of the Rectum Demonstrate Poorer Survival and Increased Need for Salvage Surgery Compared With Squamous Cancers of the Anus.
Kulaylat AS; Hollenbeak CS; Stewart DB
Dis Colon Rectum; 2017 Sep; 60(9):922-927. PubMed ID: 28796730
[TBL] [Abstract][Full Text] [Related]
16. Cancer of the anal canal.
Clark MA; Hartley A; Geh JI
Lancet Oncol; 2004 Mar; 5(3):149-57. PubMed ID: 15003197
[TBL] [Abstract][Full Text] [Related]
17. Optimal management of squamous cell carcinoma of the anal canal: where are we now?
Eng C; Ahmed S
Expert Rev Anticancer Ther; 2014 Aug; 14(8):877-86. PubMed ID: 24981728
[TBL] [Abstract][Full Text] [Related]
18. Cancer of the anal region.
Valvo F; Ciurlia E; Avuzzi B; Doci R; Ducreux M; Roelofsen F; Roth A; Trama A; Wittekind C; Bosset JF
Crit Rev Oncol Hematol; 2019 Mar; 135():115-127. PubMed ID: 30819440
[TBL] [Abstract][Full Text] [Related]
19. Extended-Field Chemoradiation Therapy for Definitive Treatment of Anal Canal Squamous Cell Carcinoma Involving the Para-Aortic Lymph Nodes.
Holliday EB; Lester SC; Harmsen WS; Eng C; Haddock MG; Krishnan S; Das P; Hallemeier CL
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):102-108. PubMed ID: 29907489
[TBL] [Abstract][Full Text] [Related]
20. Locally Recurrent Disease Related to Anal Canal Cancers.
Sammour T; Rodriguez-Bigas MA; Skibber JM
Surg Oncol Clin N Am; 2017 Jan; 26(1):115-125. PubMed ID: 27889030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
